anticoagulant sodium citrate

Generic: trisodium citrate dihydrate

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name anticoagulant sodium citrate
Generic Name trisodium citrate dihydrate
Labeler baxter healthcare corporation
Dosage Form SOLUTION
Routes
EXTRACORPOREAL
Active Ingredients

trisodium citrate dihydrate 40 mg/mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 0338-9669
Product ID 0338-9669_8855e600-2002-4c8b-94dc-d275de33169b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number BN980123
Listing Expiration 2027-12-31
Marketing Start 2024-04-02

Pharmacologic Class

Classes
acidifying activity [moa] anti-coagulant [epc] calcium chelating activity [moa] calculi dissolution agent [epc] decreased coagulation factor activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 03389669
Hyphenated Format 0338-9669

Supplemental Identifiers

UNII
B22547B95K

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name anticoagulant sodium citrate (source: ndc)
Generic Name trisodium citrate dihydrate (source: ndc)
Application Number BN980123 (source: ndc)
Routes
EXTRACORPOREAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/mL
source: ndc
Packaging
  • 250 mL in 1 BAG (0338-9669-01)
source: ndc

Packages (1)

0338-9669-01 250 mL in 1 BAG (0338-9669-01)

Ingredients (1)

trisodium citrate dihydrate (40 mg/mL)

Linked Drug Pages (1)

ANTICOAGULANT SODIUM CITRATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["EXTRACORPOREAL"], "spl_id": "8855e600-2002-4c8b-94dc-d275de33169b", "openfda": {"unii": ["B22547B95K"], "spl_set_id": ["7025a0f9-1a56-4416-a3a4-925d755aed90"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "250 mL in 1 BAG (0338-9669-01)", "package_ndc": "0338-9669-01", "marketing_start_date": "20240402"}], "brand_name": "ANTICOAGULANT SODIUM CITRATE", "product_id": "0338-9669_8855e600-2002-4c8b-94dc-d275de33169b", "dosage_form": "SOLUTION", "pharm_class": ["Acidifying Activity [MoA]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Decreased Coagulation Factor Activity [PE]"], "product_ndc": "0338-9669", "generic_name": "trisodium citrate dihydrate", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ANTICOAGULANT SODIUM CITRATE", "active_ingredients": [{"name": "TRISODIUM CITRATE DIHYDRATE", "strength": "40 mg/mL"}], "application_number": "BN980123", "marketing_category": "NDA", "marketing_start_date": "20240402", "listing_expiration_date": "20271231"}